Acquired Pure Red Cell Aplasia and Recombinant Erythropoietin

Recombinant erythropoietin (rEPO)-associated immunologically driven acquired pure red cell aplasia (PRCA) is an underreported, potentially worsening clinical syndrome in the setting of treatment of anemia of chronic kidney disease. Most cases reported in world literature are related to different for...

Descripción completa

Detalles Bibliográficos
Autores principales: Padhi, Somanath, Panda, Sandip K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443105/
https://www.ncbi.nlm.nih.gov/pubmed/34584346
http://dx.doi.org/10.4103/ijn.IJN_229_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443105/
https://www.ncbi.nlm.nih.gov/pubmed/34584346
http://dx.doi.org/10.4103/ijn.IJN_229_20

Ejemplares similares